Advisory
Statement on Congressional Passage of Reauthorization of the Prescription Drug User Fee Act
We applaud Congressional passage of the reauthorization of the Prescription Drug User Fee Act. The number of drug shortages has tripled in the last six years and the shortages have affected patient care.
Key Resources
Related Resources
AHA Center for Health Innovation Market Scan